Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Fort Mill, SC, US. The stock last traded at $0.28, down 5.77% on the session, giving a market capitalisation of $743,392. On trailing twelve-month figures it carries a trailing P/E of -0.04, a net margin of -1338.3%. Its beta of 0.48 implies it has historically moved less than the broad market.
Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.
Catheter Precision, Inc. is most often compared with the following Healthcare names: